UCB Ventures
UCB's evergreen corporate VC (2017) backs early-stage cell/gene therapy, RNA modulation and regenerative medicine startups beyond its core focus.
Investment Focus
Cell TherapyGene TherapyBioTechRegenerative MedicineRNA ModulationSynthetic BiologyNeurologyImmunologyDigital HealthHealthTech
Founded
2017
Investment Themes
Corporate VC
Thesis-Driven
Early Stage
Bio/Health-Focused
USA-Focus
Europe-Focus
You're viewing 1 investor
Go from one investor to the complete database.
Every investor · Stages · Sectors · Locations · CSV + Excel
Get the Complete Investor Database →Similar Investors
Civilization Ventures
Pre-Seed · Seed · Series A
San Francisco
Medical Excellence Capital
Seed · Series A · Series B
New York
Amino Collective
Pre-Seed · Seed · Series A
Berlin · London
Avego BioScience Capital
Series A · Series B · Series C
Alpharetta · New York
Eisai Innovation Inc.
Seed · Series A
Cambridge · San Francisco
SymBiosis Capital Management
Series A · Series B · Series C
Bentonville
Related Investor Lists
Still just 1 investor
Get the complete database — not just this profile.
Every investor · Stages · Sectors · Locations · CSV + Excel
Get the Complete Investor Database →